A study carried out on approximately 9,000 Danish residents revealed that a specific mutation in the CHEK2 gene might increase three-fold// a woman's risk of developing breast cancer in her lifetime. The study, which was the first to examine the prevalence of the CHEK2 mutation and the cancer risk associated with it, in the general population, will be published in the July 31 edition of the Journal of Clinical Oncology.
"Our study shows that women in the general population who carry a specific CHEK2 mutation are three times as likely as women without the mutation to develop breast cancer," said Borge G. Nordestgaard, MD, Professor and Chief Physician, Department of Clinical Biochemistry, Herlev University Hospital, Denmark, and lead author of the study. "The findings suggest that CHEK2 could serve as a useful biomarker for identifying women who would benefit from heightened, regular screening for breast cancer."
CHEK2, which belongs to a class of genes known as "tumor suppressors," is responsible for repairing DNA damage and preventing the uncontrolled division of cells, which can lead to cancer. In this study, researchers looked for a specific mutation, known as CHEK2*1100delC, which impairs the gene's ability to fix damage to DNA.
Previous case-control studies have shown an association between this specific CHEK2 mutation and breast, prostate, and colorectal cancer. Researchers designed this study to assess the prevalence of the mutation in the population at large and to examine its impact on cancer risk.
Dr. Nordestgaard and his colleagues randomly selected 9,231 Danes who had participated in the Copenhagen City Heart Study--a cohort of more than 20,000 Danish men and women that followed were monitored for an average of 34 years for cancer development.
The researchers found that 0.5% of all participants carried the CHEK2 mutation. Among women who carried the CHEK2 mutation, 12% developed breast cancer, Page: 1 2 Related medicine news :1
. Mutation connected to Osteoporosis2
. Stem Cells Have Few Mutations3
. Gene Mutation Causes Ovarian Failure4
. Mutations in NOTCH1 cause an early developmental defect in the aortic valve5
. A Word Of Caution: Routine Screening For Breast Cancer Mutation Not Advisdable6
. Coffee Reduces Risk of Breast Cancer in BRCA1 Mutation Carriers7
. CCR5 Mutation Confers Immunity Against HIV But Not Against West Nile Virus Illness8
. Wound Healing Accelerated By Mutation In Deafness Gene9
. No Mutation Of Bird Flu Virus: WHO10
. Gene Mutation May Influence Age at Onset of Parkinsons Disease11
. Menin Gene Mutation made Insulin Secreting Cells to Proliferate